Azithromycin treatment modifies airway and blood gene expression networks in neutrophilic COPD Source: ERJ Open Res, 4 (4) 00031-2018; 10.1183/23120541.00031-2018 Year: 2018
A nasal gene expression profile differentiates individuals with and without COPD and overlaps bronchial gene expression Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases Year: 2017
Increased sputum FKBP51 gene expression following Azithromycin add-on therapy in asthma Source: International Congress 2018 – New modalities in asthma treatment Year: 2018
T17 gene asthma signature characterized by sputum neutrophilia and regular use of antibiotics Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017
Effect of QVAR® on inflammatory cells and cytokine gene expression in early and late sputum samples in asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 502s Year: 2002
Modulation of sputum gene expression in COPD by fluticasone/salmeterol Source: Eur Respir J 2006; 28: Suppl. 50, 662s Year: 2006
Characterisation and mRNA expression analysis of the bronchial hyperresponsiveness susceptibility gene protocadherin-1 in asthma patients Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009
Long-term use of ICS influence TLR2 expression on induced sputum from severe COPD patients Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond Year: 2012
Differential expression of mRNA encoding for pro-inflammatory and angiogenic proteins in aspirin-tolerant and -intolerant asthma, following oral provocative aspirin challenge Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Elevated serum IgE, oral corticosteroid dependence and IL-17/22 expression in highly neutrophilic asthma Source: Eur Respir J, 54 (5) 1900068; 10.1183/13993003.00068-2019 Year: 2019
Effect of switching from high-dose inhaled corticosteroid (ICS) to low-dose ICS plus an inhaled long-acting β2 -agonist on asthma control, airway inflammation and remodeling, and gene expression in airway epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 35s Year: 2003
The six-gene expression signature in whole sampled sputum provides clinically feasible inflammatory phenotyping of asthma Source: ERJ Open Res, 6 (1) 00280-2019; 10.1183/23120541.00280-2019 Year: 2020
Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011
Monitoring of inflammatory changes in patients with bronchial asthma before and after oral corticosteroid treatment Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008
Evidence of a distinct phenotype of adult onset asthma characterized by an airway neutrophilia and poor response to inhaled corticosteroids Source: Eur Respir J 2001; 18: Suppl. 33, 21s Year: 2001
High sputum eosinophils are associated with better response to inhaled corticosteroids in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 113s Year: 2002
Gene expression in bronchial biopsies from subjects with persistent asthma and asthma in remission Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017
Sputum cells profile and airway responsiveness in different asthma phenotypes in children Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood Year: 2010
Effect of long-term corticosteroid treatment on microRNA and gene-expression profiles in COPD Source: Eur Respir J, 53 (4) 1801202; 10.1183/13993003.01202-2018 Year: 2019
Does sputum eosinophil counts predict the response to inhaled corticosteroids in terms of methacholine bronchial responsiveness in steroid naive asthmatics? Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001